Alleviant Medical develops transcatheter technology designed to lift the clinical and economic burden of heart failure.
Alleviant Medical has raised $90.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2025.
Alleviant Medical's investors include S3 Ventures, Omega Funds, Shangbay Capital, Vensana Capital, MassChallenge.
Alleviant Medical is headquartered in Austin, United States.
Alleviant Medical develops transcatheter technology designed to lift the clinical and economic burden of heart failure.
Alleviant Medical is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Alleviant Medical — Funding & Investors." VCBacked, January 14, 2025, https://www.vcbacked.co/company/alleviant-medical. Accessed July 20, 2026.
VCBacked. (2025). Alleviant Medical — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/alleviant-medical
{{cite web |title=Alleviant Medical — Funding & Investors |url=https://www.vcbacked.co/company/alleviant-medical |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated